Holland & Barrett has seen an 11% increase in total sales to £806.1m for the year ending September 2023, driven by a £70m investment in stores, technology, and product development. Gross profit rose 7% to £475.7m, while EBITDA decreased to £81.9m due to new accounting policies and growth investments. Executive chair Alex Gourlay highlighted the shift towards preventive health and the company’s commitment to transformation and customer accessibility.
The Elizabeth Holmes/Theranos story is fascinating.
October 25, 2026
